Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Three‐Dimensional‐Printed Models Reduce Adverse Events of Left Atrial Appendage Occlusion: A Systematic Review and Meta‐Analysis

View through CrossRef
ABSTRACTBackground and AimsLeft atrial appendage occlusion (LAAO) has an excellent safety profile but there is growing evidence of adverse long‐term sequelae of peri‐device leak and device‐related thrombus. This study seeks to determine if guidance from 3D‐printed models of left atrial appendages reduces the incidence of side effects.MethodsA systematic literature search was conducted in the following databases: Pubmed, Google Scholar, and Europe PMC. Cohort studies that directly compared outcomes using 3D‐printed model simulations before undergoing LAAO versus using conventional imaging only among patients with nonvalvular atrial fibrillation, CHA2DS2‐VASc scores ≥ 1, and relative or absolute contraindications to long‐term anticoagulation were included. Clinical outcomes included incidence of peri‐device leak, mismatch, and device‐related thrombus. Meta‐analysis was done using the random‐effects model.ResultsOnly three cohort studies were eligible for meta‐analysis with a mean follow‐up period of 25 months. This included a total of 204 patients (mean age, 75 years). Using 3D printed models of left atrial appendage based on transesophageal echocardiogram and cardiac computed tomography had statistically significantly less incidence of peri‐device leak (log OR −2.47; 95% CI: −3.70 to 1.24; p = 0.00), incidence of mismatch (log OR −1.61; 95% CI: −2.50 to 0.73; p = 0.00) and shorter procedural time (mean difference −24.86; 95% CI: −31.75 and −27.11; p = 0.00). Although the incidence of device‐related thromboembolism was 49% less in the 3D printing‐guided group, the difference was not statistically significant (p = 0.58).ConclusionLess incidence of peri‐device leak and mismatch were observed with 3D printing‐guided left atrial appendage occlusion. A highly powered randomized controlled trial may have to be done to confirm the findings.
Title: Three‐Dimensional‐Printed Models Reduce Adverse Events of Left Atrial Appendage Occlusion: A Systematic Review and Meta‐Analysis
Description:
ABSTRACTBackground and AimsLeft atrial appendage occlusion (LAAO) has an excellent safety profile but there is growing evidence of adverse long‐term sequelae of peri‐device leak and device‐related thrombus.
This study seeks to determine if guidance from 3D‐printed models of left atrial appendages reduces the incidence of side effects.
MethodsA systematic literature search was conducted in the following databases: Pubmed, Google Scholar, and Europe PMC.
Cohort studies that directly compared outcomes using 3D‐printed model simulations before undergoing LAAO versus using conventional imaging only among patients with nonvalvular atrial fibrillation, CHA2DS2‐VASc scores ≥ 1, and relative or absolute contraindications to long‐term anticoagulation were included.
Clinical outcomes included incidence of peri‐device leak, mismatch, and device‐related thrombus.
Meta‐analysis was done using the random‐effects model.
ResultsOnly three cohort studies were eligible for meta‐analysis with a mean follow‐up period of 25 months.
This included a total of 204 patients (mean age, 75 years).
Using 3D printed models of left atrial appendage based on transesophageal echocardiogram and cardiac computed tomography had statistically significantly less incidence of peri‐device leak (log OR −2.
47; 95% CI: −3.
70 to 1.
24; p = 0.
00), incidence of mismatch (log OR −1.
61; 95% CI: −2.
50 to 0.
73; p = 0.
00) and shorter procedural time (mean difference −24.
86; 95% CI: −31.
75 and −27.
11; p = 0.
00).
Although the incidence of device‐related thromboembolism was 49% less in the 3D printing‐guided group, the difference was not statistically significant (p = 0.
58).
ConclusionLess incidence of peri‐device leak and mismatch were observed with 3D printing‐guided left atrial appendage occlusion.
A highly powered randomized controlled trial may have to be done to confirm the findings.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
OBJECTIVE To determine whether there is significant atrial or atrial appendage enlargement or functional remodelling as a result of one to two months of sustained...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract Introduction Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...

Back to Top